merck

More than a third of the Dow Jones Industrials are on deck to report quarterly results this week. Wall Street expectations are perhaps highest for a chemicals giant and a leading credit services company. However, just one of these two is expected to show growth on the top line. The third-quarter...

Three leading biotech companies will step into the earnings spotlight this week. Consensus forecasts from Wall Street analysts call for earnings growth from just two of them. And only one of them has topped estimates by double-digits in recent quarters. While the biotechnology industry has had a...

Among the earnings highlights for the week will be the reports from two major pharmaceutical companies. Wall Street analysts are looking for earnings growth from only one of them. Both companies have exceeded earnings estimates in recent quarters. The earnings season rolls on even as...

This weekend in Barron's online: bargains galore after the sell-off, more turmoil ahead China and Asia, as well as the prospects for PayPal and more. Cover Story "Bargains Beckon as U.S. Stocks Bottom" by Andrew Bary. After last week's market sell-off and rebound, the worst may be over, says this...

This weekend in Barron's online: airline stocks ready to take off, the 50 best annuities in America, mega vacations of the super wealthy, as well as the prospects for Merck, Nintendo, the Bio-Reference Labs buyout and more. Cover Story "Airline Stocks Could Soar Up to 50% in a Year...

The first-quarter earnings season rolls on this week, and perhaps the most anticipated report of the week, if not the quarter, will come from Apple Inc. (NASDAQ: AAPL). Investors and Wall Street are looking for spectacular results. Analysts' forecasts also call for earnings growth from Time Warner...

Johnson & Johnson (NYSE: JNJ) came out with better-than-expected earnings on Tuesday, despite the strong headwind it faced from the rising dollar. The company reported first-quarter EPS of $1.56, compared to $1.54 in the same quarter last year, while revenue dropped to $17.4 billion, from $18...

Merck & Co., Inc. (NYSE: MRK) has rewarded shareholders in the stock with a "triple" off of the $20.07 low set in March of 2009. With valuations for Merck getting stretched -- the dividend yield of half of what it was in 2009 and the technicals weakening -- can the bulls in the...

It is clear that the mixed earnings results seen so far have contributed to the volatility in the markets throughout January. While many of the market movers have already shared their most recent quarterly results, there are plenty more on tap as February gets started. Among the most...

Lots more earnings are on tap this week, from social media giants like Facebook and Twitter to petroleum supermajors Exxon and Chevron, from major pharmaceutical makers Merck and Pfizer to consumer goods giants like Altria and Avon Products. Here is a quick look at what analysts are expecting from...

U.S. markets began the week on a negative note after markets sold off in the final two hours of trading on no major news catalyst. The S&P 500 fell through its 200-day moving average of 1,905, a key technical level for fundamental investors and traders. The last time the index broke its 200...